跳至主要内容
临床试验/DRKS00024663
DRKS00024663招募中未知

Virtual reality-based meditation for enhancement of wellbeing, quality of life and patient satisfaction for in-patients undergoing chemotherapy

niversitätsklinikum Augsburg0 个研究点目标入组 40 人开始时间: 2021年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Adult patients capable of consent who are receiving inpatient chemotherapy for lung cancer or acute myeloid or acute lymphatic leukemia.

排除标准

  • Non-consenting patients; minor patients; pregnant patients; patients admitted as emergencies; patients participating in another intervention study that may have a potential impact on the endpoints of this study; Patients with infectious disease and need for isolation, pre-existing dementia, schizophrenia, hallucinations, panic attacks, or epileptic seizures; pacemaker or defibrillator wearers; patients taking neuroleptics or antiepileptic drugs; patients with active alcohol and/or drug abuse; lack of proficiency in German or English.

研究者

发起方
niversitätsklinikum Augsburg

相似试验